Assessment of Bone Mineral Density During Pregnancy

A

Ain Shams University

Status and phase

Completed
Phase 1

Conditions

Bone Mineral Density Quantitative Trait Locus 3

Treatments

Radiation: calcaneal quantitative ultrasound assessment

Study type

Interventional

Funder types

Other

Identifiers

NCT02480023
osteopenia during pregnancy

Details and patient eligibility

About

BMD at peripheral sites typically heel is measured by Ultrasound densitometry at Ain Shams Maternity hospital.

Full description

Consecutive patients with singleton pregnancies between 36 and 39 weeks booked at a general obstetric clinic in a regional hospital will be recruited for the study. The obstetric department is a tertiary referral center in the region and part of a university teaching unit which catered to an annual delivery of around 10,000 women. A group of first trimester pregnant women with nearly the same age is recruited as controls.

Enrollment

173 patients

Sex

Female

Ages

20 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

1. females during 3rd trimister

Exclusion criteria

  • Secondary causes of bone loss such as hyperparathyroidism.
  • Co-morbidities that would interfere with bone metabolism as clinically significant liver or renal disease.
  • Physical or orthopedic disabilities that would place the subject at risk or limit their ability to perform US.
  • Taking medication known to affect bone including steroid hormones.

Histories of smoking and use of oral contraceptives (OCs) are not exclusion criteria.

Trial design

173 participants in 1 patient group

healthcare
Experimental group
Description:
QUS for calcaneus bone of right foot will be done for this group of Pregnant women at the third trimester
Treatment:
Radiation: calcaneal quantitative ultrasound assessment

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems